Mariakerke, Belgium

Bert Devriendt

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Universiteit Gent. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bert Devriendt. Retrieved from https://idiyas.com/inventor/bert-devriendt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bert Devriendt and His Work in Mucosal Vaccine Delivery.

Introduction

Bert Devriendt is an inventor associated with Mariakerke, Belgium. His patent work includes research into single-domain antibodies for delivering mucosal vaccines.

Latest Patents

One patent is listed for Bert Devriendt: Immunoglobulin Single Domain Antibodies for Delivery of Mucosal Vaccines. The patent addresses the use of single-domain antibodies in mucosal vaccine delivery. His listed patent portfolio comprises 1 patent.

Career Highlights

Devriendt is associated with Universiteit Gent, also known as Ghent University. His work connects academic research with innovation in antibody-based vaccine delivery.

Collaborations

His listed coworkers include Eric Cox and Anna Depicker. Their names reflect professional connections associated with his research and patent activity.

Conclusion

Bert Devriendt’s patent on immunoglobulin single-domain antibodies highlights his contribution to research on mucosal vaccine delivery.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…